Teladoc Health, Inc. (TDOC) – What Are Researchers Saying About This Stock?

Shares of Teladoc Health, Inc. (NYSE:TDOC) have been given a consensus rating of “Hold” by the sixteen research firms that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and five have assigned a buy rating to the company. The average 1 year target price among analysts that have covered the stock in the last year is $7.54.

Several analysts have recently commented on TDOC shares. Bank of America increased their price objective on Teladoc Health from $9.00 to $10.50 and gave the stock a “buy” rating in a research note on Tuesday, July 7th. Canaccord Genuity Group dropped their target price on Teladoc Health from $11.00 to $10.00 and set a “buy” rating on the stock in a report on Thursday, July 30th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Teladoc Health in a research report on Wednesday, August 19th. Finally, Citigroup cut their target price on Teladoc Health from $11.00 to $7.50 and set a “neutral” rating on the stock in a research report on Monday, August 3rd.

Teladoc Health Price Performance

Shares of NYSE TDOC opened at $5.68 on Wednesday. The stock has a market capitalization of $1.03 billion, a P/E ratio of -5.74 and a beta of 2.14. The company has a 50-day moving average price of $6.22 and a 200-day moving average price of $6.89. Teladoc Health has a 1 year low of $4.40 and a 1 year high of $9.89.

Teladoc Health (NYSE:TDOC) last posted its earnings results on Wednesday, July 29th. The health services provider reported ($0.21) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.25) by $0.04. Teladoc Health had a negative net margin of 7.13% and a negative return on equity of 12.15%. The company had revenue of $606.93 million for the quarter, compared to analyst estimates of $615.44 million. During the same quarter in the prior year, the business posted ($0.19) EPS. The firm’s revenue was down 4.0% compared to the same quarter last year. Teladoc Health has set its Q3 2026 guidance at -0.300–0.200 EPS and its FY 2026 guidance at -1.000–0.750 EPS. As a group, equities research analysts anticipate that Teladoc Health will post -0.92 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Teladoc Health news, CEO Charles III sold 17,805 shares of Teladoc Health stock in a transaction on Friday, September 11th. The shares were sold at an average price of $6.10, for a total transaction of $108,610.50. Following the transaction, the chief executive officer directly owned 465,535 shares of the company’s stock, valued at $2,839,763.50. The trade was a 3.68% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Company insiders own 0.70% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in TDOC. Versant Capital Management Inc raised its stake in shares of Teladoc Health by 33.3% during the 2nd quarter. Versant Capital Management Inc now owns 8,207 shares of the health services provider’s stock worth $70,000 after purchasing an additional 2,052 shares during the period. HighTower Advisors LLC grew its position in Teladoc Health by 20.8% during the second quarter. HighTower Advisors LLC now owns 16,808 shares of the health services provider’s stock valued at $143,000 after buying an additional 2,893 shares during the period. Allworth Financial LP bought a new position in Teladoc Health during the second quarter valued at about $25,000. Twin Lakes Capital Management LLC purchased a new stake in Teladoc Health during the second quarter worth about $26,000. Finally, Nykredit A S purchased a new stake in Teladoc Health during the second quarter worth about $27,000. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

About Teladoc Health

Teladoc Health, Inc (NYSE: TDOC) provides virtual healthcare services and technology that connect patients with physicians, therapists and other healthcare professionals. Its platform supports general medical care, specialist consultations, mental health services, chronic condition management and related healthcare programs through digital and remote-care channels.

The company’s offerings include Teladoc’s telehealth services, BetterHelp’s online counseling and therapy platform, and chronic care solutions developed through Livongo, which Teladoc acquired in 2020.